Amin J - Search Results

1

Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis.

Teeraananchai S, Kerr SJ, Amin J, Ruxrungtham K, Law MG. Teeraananchai S, et al. Among authors: amin j. HIV Med. 2017 Apr;18(4):256-266. doi: 10.1111/hiv.12421. Epub 2016 Aug 31. HIV Med. 2017. PMID: 27578404 Free article.

2

Combined analysis of two-year follow-up from two open-label randomized trials comparing efficacy of three nucleoside reverse transcriptase inhibitor backbones for previously untreated HIV-1 infection: OzCombo 1 and 2.

Amin J, Moore A, Carr A, French MA, Law M, Emery S, Cooper DA; OzCombo 1 and 2 Investigators. Amin J, et al. HIV Clin Trials. 2003 Jul-Aug;4(4):252-61. doi: 10.1310/K2U9-QC2V-1Y3V-5DYF. HIV Clin Trials. 2003. PMID: 12916011 Clinical Trial.

3

HIV and hepatitis C coinfection within the CAESAR study.

Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ. Amin J, et al. HIV Med. 2004 May;5(3):174-9. doi: 10.1111/j.1468-1293.2004.00207.x. HIV Med. 2004. PMID: 15139984 Free article. Clinical Trial.

4

The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxis.

Winston A, McAllister J, Amin J, Cooper DA, Carr A. Winston A, et al. Among authors: amin j. HIV Med. 2005 May;6(3):191-7. doi: 10.1111/j.1468-1293.2005.00288.x. HIV Med. 2005. PMID: 15876286 Free article.

5

Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy.

Winston A, Amin J, Mallon P, Marriott D, Carr A, Cooper DA, Emery S. Winston A, et al. Among authors: amin j. HIV Med. 2006 Mar;7(2):105-11. doi: 10.1111/j.1468-1293.2006.00349.x. HIV Med. 2006. PMID: 16420255 Free article.

6

Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users.

Amin J, Law MG, Micallef J, Jauncey M, Van Beek I, Kaldor JM, Dore GJ. Amin J, et al. Epidemiol Infect. 2007 Jan;135(1):144-50. doi: 10.1017/S0950268806006388. Epub 2006 May 17. Epidemiol Infect. 2007. PMID: 16707030 Free PMC article.

7

Modelling and calibration of the hepatitis C epidemic in Australia.

Razali K, Amin J, Dore GJ, Law MG, HCV Projections Working Group. Razali K, et al. Among authors: amin j. Stat Methods Med Res. 2009 Jun;18(3):253-70. doi: 10.1177/0962280208094689. Epub 2008 Nov 26. Stat Methods Med Res. 2009. PMID: 19036911

8

Hospitalization rates associated with hepatitis B and HIV co-infection, age and sex in a population-based cohort of people diagnosed with hepatitis C.

Gidding HF, Amin J, Dore GJ, Law MG. Gidding HF, et al. Among authors: amin j. Epidemiol Infect. 2011 Aug;139(8):1151-8. doi: 10.1017/S095026881000258X. Epub 2010 Nov 19. Epidemiol Infect. 2011. PMID: 21087540

9

Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.

Thein HH, Walter SR, Gidding HF, Amin J, Law MG, George J, Dore GJ. Thein HH, et al. Among authors: amin j. J Viral Hepat. 2011 Jul;18(7):e232-41. doi: 10.1111/j.1365-2893.2011.01440.x. Epub 2011 Feb 17. J Viral Hepat. 2011. PMID: 21692938

10

Lower life expectancy among people with an HCV notification: a population-based linkage study.

Alavi M, Law MG, Grebely J, Thein HH, Walter S, Amin J, Dore GJ. Alavi M, et al. Among authors: amin j. J Viral Hepat. 2014 Jun;21(6):e10-8. doi: 10.1111/jvh.12245. J Viral Hepat. 2014. PMID: 24827903

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

492 results

Search Page